Role of high-dose interleukin-2 for melanoma in the age of cellular therapy by Mario Sznol, Elizabeth Buchbinder, Rodabe Amaria, Amod Sarnaik, David F McDermott, Michael B Atkins, Ann W Silk, Kim A Margolin, Michael T Lotze, Zeynep Eroglu, Virginia Seery, Allison Betof Warner, Harriet M Kluger, Karam Khaddour

Get full text

CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion by Chao Wang, Shari Pilon-Thomas, Daniel Abate-Daga, Anders Berglund, Amod Sarnaik, Dongliang Du, James J Mulé, Leticia Tordesillas, Yian Ann Chen, Sebastian Snedal, Junior Cianne, Benjamin Creelan, Renata Ariza Marques Rossetti, Matthew S Beatty, Elena Martinez Planes, Bradford A Perez

Get full text

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint... by Jessica C Hassel, James Larkin, Madan Jagasia, Harriet Kluger, Omid Hamid, Jeffrey Weber, Jason Chesney, Amod Sarnaik, John M Kirkwood, Eric Whitman, Martin Wermke, Evidio Domingo-Musibay, Theresa Medina, Sajeve Thomas, Wen Shi, Xiao Wu, Nikhil I Khushalani, Parameswaran Hari, Marlana Orloff, Mike Cusnir, Giao Q Phan, Andrew J S Furness, Michael E Egger, Friedrich Graf Finckenstein, Giri Sulur

Get full text